GPT and neoplasm: There was no significant difference between the GPC-3-positive and -negative expression in the laboratory indicators of liver function, including TB, DBil, AST, ALT, TP and GLB (P>0.05); laboratory indicators of coagulation, including PT, PLT and INR (P>0.05); and laboratory indicators of tumor markers, including AFP, CA242, CYFRA211 and TSGF (P>0.05).